Abstract:Abstract Abstract 4425 Notch gene family encodes single pass transmembrane receptors able to transducer intercellular signals involved in cell-fate determination. Notch signaling is the leading causes to the development of malignant tumors. Notch pathway plays a role in haematopoiesis affecting both stem cells and committed progenitors. The expression of Notch1 in thymic stromal cells and in developing thymocytes is consistent with Notch function. Notch1 is turn on before T-cell commitment along the lymphoid development; a variety of model systems indicates that Notch1 signaling is required for the earliest stages of T-cell commitment in the thymus and that, in its absence, cells develop toward the B-lineage. Overexpression of Notch1 gene was found in T-ALL, however, little is known the expression pattern of Notch1 gene in the different lymphoid malignancies. In the present study, the expression level of Notch1 gene was analyzed in patients with lymphoid malignancies. Real-time PCR with SYBR Green I technique was used for detecting Notch1 gene expression level in peripheral blood mononuclear cells of 43 patients with lymphoid malignancies [including 7 cases with T-ALL, 6 cases with T-NHL, 9 cases with B-ALL, 5 cases with B-CLL, 16 cases with B-NHL] and 20 healthy individuals. β2-microglobulin gene (β2M) was used as an endogenous reference. Relative changes in Notch1 gene expression level were used by the 2-ΔCt×100% ×100% method. The expression level of Notch1 in both T-cell lymphoid malignancies group (Median: 0.897%) and B-cell lymphoid malignancies group (Median: 0.726%) was significant higher than those in the healthy control (Median: 0.288%) (P<0.01, P<0.01). Moreover, the expression level of Notch1 was different in the five types of lymphoid malignancies. That is, the highest in the B-CLL group, secondary in the T-NHL group, the lowest in the B-NHL group. And, it is not significant different between the B-NHL and healthy control groups. In conclusions, Overexpression of Notch1 gene was found not only in T-ALL, but also in T-NHL and B-cell leukemia and suggests that the abnormal overexpression pattern of Notch1 might play an important role in the pathogenesis of lymphoid malignancies. Down-regulation of Notch1 might be considered as target therapeutic strategy for lymphocytic malignancies. Disclosures: Zheng: The study was supported by grants from National Natural Science Foundation of China (No. 30871091): Research Funding. Yang:The study was supported by grants from National Natural Science Foundation of China (No. 30871091): Research Funding. Chen:The study was supported by grants from National Natural Science Foundation of China (No. 30871091): Research Funding. Zhong:The study was supported by grants from National Natural Science Foundation of China (No. 30871091): Research Funding. Li:The study was supported by grants from National Natural Science Foundation of China (No. 30871091): Research Funding.

The emerging roles of Notch signaling in leukemia and stem cells

Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia

Role of Notch signaling pathway in pathogenesis of leukemia and angiogenesis]

Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia

Progress of Study on Notch and Hematologic Malignancies——Review

Recent Researches on the Notch Signaling Pathway

A Regulatory Loop Involving Notch and Wnt Signaling Maintains Leukemia Stem Cells in T-Cell Acute Lymphoblastic Leukemia

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Downregulating Notch Signaling in KrasG12D/+ Mice Inhibits Both T-Cell Leukemia and Myeloproliferative Neoplasm in a Cell-Autonomous Manner

DDX5 is a Positive Regulator of Oncogenic NOTCH1 Signaling in T Cell Acute Lymphoblastic Leukemia

Notch Signaling in the Bone Marrow Lymphopoietic Niche

Notch Signaling Maintains Proliferation and Survival of the HL60 Human Promyelocytic Leukemia Cell Line and Promotes the Phosphorylation of the Rb Protein

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond

Canonical Notch Signaling Is Required for KrasG12D-Induced Myeloproliferative Neoplasm

Notch Signaling Pathway Networks in Cancer Metastasis: a New Target for Cancer Therapy

Delineating Notch1 and Notch2: Receptor‐Specific Significance and Therapeutic Importance of Pinpoint Targeting Strategies for Hematological Malignancies

Ddx5 Modulates Notch Signaling Via Interaction With The Maml1 Co-Activator And Is Required To Optimal Notch Signaling In Leukemic Cells

Notch1 is Required for Hypoxia-Induced Proliferation, Invasion and Chemoresistance of T-cell Acute Lymphoblastic Leukemia Cells

Change of the Notch1 Expression Level in Lymphoid Malignancies.

Notch signaling pathway: architecture, disease, and therapeutics

A Role for Notch Signaling in Lymphoid Progenitor Development in the Bone Marrow